Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 4 | 0 | 0 | 0 | 0 |
| Gross Profit | 4 | N/A | N/A | N/A | N/A |
| Operating Expenses | 4,248 | 3,057 | 2,149 | 2,189 | 2,344 |
| Operating Income | -4,244 | -3,057 | -2,149 | -2,189 | -2,344 |
| Other Income | 26 | 41 | 9 | 10 | 11 |
| Pre-tax Income | -4,218 | -3,016 | -2,140 | -2,179 | -2,333 |
| Net Income Continuous | -4,218 | -3,016 | -2,140 | -2,179 | -2,333 |
| Net Income | $-4,218 | $-3,016 | $-2,140 | $-2,179 | $-2,333 |
| EPS Basic Total Ops | -0.45 | -0.30 | -0.20 | -0.25 | -0.25 |
| EPS Basic Continuous Ops | -0.45 | -0.32 | -0.23 | -0.23 | -0.25 |
| EPS Diluted Total Ops | -0.45 | -0.30 | -0.20 | -0.25 | -0.25 |
| EPS Diluted Continuous Ops | -0.45 | -0.32 | -0.23 | -0.23 | -0.25 |
| EBITDA(a) | $-4,210 | $-3,023 | $-2,116 | $-2,157 | $-2,312 |